Key facts
- The American Diabetes Association's Innovation Fund invested in UpDoc.
- UpDoc's platform uses patient-facing AI agents for chronic disease management.
- The investment aims to accelerate AI-driven chronic disease care.
- Funding will support scaling UpDoc's clinical AI platform.
The American Diabetes Association's Innovation Fund has announced a strategic investment in UpDoc, a company focused on AI-driven chronic disease management. This investment is intended to accelerate the development and deployment of UpDoc's clinical AI platform, which utilizes patient-facing AI agents. The goal is to transform chronic disease care and prevention on a large scale, leveraging artificial intelligence to improve patient outcomes and operational efficiency within the healthcare system.